57th ASH Annual Meeting and Exposition (December 5-8, 2015): 901. Health Services and Outcomes Research

Health Services and Outcomes Research – Non-Malignant Conditions Oral and Poster Abstracts
Poster

Hall A, Level 2 (Orange County Convention Center)

2057

Central Venous Access Device (CVAD) Use and Complications in Sickle Cell Disease Patients from Medicaid and Commercially-Insured U.S. Populations

Nancy Maserejian, ScD^*, Cortney Hayflinger, MS^*, Susan Eaton, MSPH^*, Catherine Madigan, MD^* and William E. Hobbs, MD/PhD

Biogen, Cambridge, MA

2058

Does the Timing of Vital Sign Measurements Affect Simplified Pulmonary Embolism Severity Index (sPESI) Risk Determination?

Christine G Kohn, PharmD¹^*, Heather Rozjabek, MPH²^*, Gregory J Fermann, MD³^*, W Frank Peacock, MD, FACEP⁴^*, Concetta Crivera⁵^*, Jeff Schein⁵^* and Craig I Coleman, PharmD⁶^*

¹School of Pharmacy, University of Saint Joseph, Hartford, CT
²Janssen Scientific Affairs LLC, Raritan, NJ
³University Cincinnati Medical Center, Cincinnati, OH
⁴Emergency Medicine, Baylor College of Medicine, Houston, TX
⁵Janssen Scientific Affairs, LLC, Raritan, NJ
⁶School of Pharmacy, University of Connecticut, Storrs, CT

2059

Efficiency of Diagnosing HIT at a Large Academic Medical Center

Marcia N Paddock, MD, PhD¹, Bryce Clark¹^* and Maria Teresa De Sancho, MD, MSc²

¹New York Presbyterian/Cornell, New York, NY
²Medicine, Division of Hematology-Oncology, Weill Cornell Medical College, New York, NY

2060

National Epidemiology of Venous Thromboembolism in Patients with Malignancy in United States from 1993 to 2012

Kathan Dilipbhai Mehta, MBBS, MPH¹, Leonard Appleman, MD, PhD¹^*, Hong Wang, PhD²^*, Roy E. Smith, MD³ and Rahul Atul Parikh, MD, PhD²^*

¹University of Pittsburgh Medical Center, Pittsburgh, PA
²University of Pittsburgh, Pittsburgh, PA
³Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA

2061

Characteristics and Treatment Patterns of Patients with Deep Vein Thrombosis and/or Pulmonary Embolism in the US Hospital Setting

Matthew Sussman¹^*, Jonathan Lim²^*, Cheng Wang²^*, Mark Friedman, MD¹^*, Stephen Sander²^* and Robert Griffiths¹^*

¹Boston Health Economics Inc, Waltham, MA
²Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT

2062

The Effect of Iron Deficiency without Anemia on Cardiovascular Fitness: A Nhanes Study

Mohammed Shaik, MD, MS¹^*, Mohamed Akkad, MD¹^* and Anas Al-Janadi, MD²

¹Breslin Cancer Center, Lansing, MI
²Breslin Cancer Center, MSU, Lansing, MI

2063

The Prevalence of Mood and Alcohol Related Disorders within the Adult Sickle Cell Disease Population and Their Impact on Healthcare Utilization

Sonya J. Bruton, MA, MPA¹^*, Mehdi Nouraie, MD, PhD², Denise M. Scott, MS, PhD³^*, Thomas Gilmore, PhD⁴^* and Robert E. Taylor, MD, PhD⁵

¹The Chicago School of Professional Psychology, DC Campus, Washington, DC
²Center For Sickle Cell Disease, Howard University, Washington, DC
³Department of Pediatrics and Human Genetics, Howard University, Washington, DC
⁴The Chicago School of Professional Psychology, Washington, DC
⁵howard univ, washington

2064

A Survey of Resident Physicians' and Nurses' Knowledge of Severity Assessment of Acute Chest Syndrome and Role of Incentive Spirometry in Management

Nupur Mittal, MD¹^* and Lewis L. Hsu, MD, PhD²

¹Department of Pediatrics, Hematology/Oncology, University of Illinois at Chicago, University Of Illinois At Chicago, Chicago, IL
²Department of Pediatrics, Hematology/Oncology, University of Illinois at Chicago, Chicago, IL

2065

Prophylactic Use of Voriconazole for Invasive Fungal Infection in Children and Adolescents with Acute Myeloid Leukemia

Hirozumi Sano, M.D., Ryoji Kobayashi, MD, PhD^*, Daiki Hori, MD^*, Kenji Kishimoto, MD^*, Daisuke Suzuki, MD, PhD^*, Kazue Yasuda, MD, PhD^* and Kunihiko Kobayashi, MD, PhD^*

Pediatrics, Sapporo Hokuyu Hospital, Sapporo, Japan

2066

Annual Patient and Caregiver Burden of Oncology Clinic Visits for Granulocyte-Colony Stimulating Factor (G-CSF) Therapy in the United States (US)

Mark Stephens¹^*, Xiaoyan Li, PhD²^*, Maureen Reiner³^*, Wayne Sheldon³^* and Spiros Tzivelekis, MSc²^*

¹Prima Health Analytics, Weymouth, MA
²Amgen Inc., Thousand Oaks, CA
³Amgen, Inc., Thousand Oaks, CA

2067

Reduction in the Frequency of Emergency Department Visits for Complications Related to Sickle Hemoglobinopathies: Effects of Aggressive Hydroxyurea Therapy

Ashok Raj, MD¹, Arun Ranjan Panigrahi, MD², Scott N. Myers, MD, MPH, MSc², Jennifer Mullinax, MD³^*, John A Myers⁴^* and Pradeep Padmanabhan, MD⁵^*

¹Pediatric Blood and Cancer Disorders Clinic, Louisville, KY
²Division of Hematology/Oncology/Stem Cell Transplantation, University of Louisville, Louisville, KY
³Pediatric Hematology/Oncology/Stem cell transplantationl, University of Louisville, Louisville, KY
⁴Department of Pediatrics, University of Louisville, Louisville, KY
⁵Division of Pediatric Emergency Medicine, University of Louisville, Louisville, KY

2068

Reduced Emergency Room Utilization for Initiation of Anticoagulation with Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Thrombosis

Aaron P Soff¹^*, Judy Dong, MD¹^*, Aiqi Dong²^*, Sean Devlin, PhD³^*, Simon Mantha, MD, MPH⁴, Rekha Parameswaran, MD⁴ and Gerald A Soff, MD⁴

¹Memorial Sloan Kettering Cancer Center, New York City, NY
²Memorial Sloan-Kettering Cancer Center, New York City, NY
³Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Hematology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

2069

A Systematic Review of the Classification, Diagnosis, Treatment and Outcome of Osteonecrosis of the Hips in Sickle Cell Disease

Dalal Hamza Mulla-Ali, BCh, BAO, LRCPSI, FRCPC¹^*, Kevin H.M. Kuo, MD, MSc, FRCPC^2,3, Ambica Parmar, MD⁴^* and Yves D. Pastore, MD⁵

¹Health Sciences Center, Faculty of Medicine, Kuwait University, Jabriya, Kuwait
²Division of Hematology, Department of Medicine, University of Toronto, Toronto, ON, Canada
³Division of Medical Oncology and Hematology, Department of Medicine, University Health Network, Toronto, ON, Canada
⁴University of Toronto, Toronto, ON, Canada
⁵CHU Sainte-Justine, Montreal, QC, Canada

2070

Establishing Sickle Cell Diagnostics and Characterizing a Pediatric Sickle Cell Disease Cohort in Malawi

Jonathan Brett Heimlich¹^*, Godwin Chipoka, MBBS²^*, Portia Kamthunzi²^*, Yuri D. Fedoriw, MD³, Nigel S. Key, MB, ChB⁴, Kenneth I. Ataga, MD⁵ and Satish Gopal^2,3^*

¹2Medical College of Georgia, Georgia Regents University, Augusta, GA
²UNC Project-Malawi, Lilongwe, Malawi
³Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
⁴Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC
⁵Division of Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC

2071

Moyamoya Disease Predicts Progression of Cerebral Vasculopathy in Patients with Sickle Cell Disease Despite Chronic Transfusion Therapy

Alyssa M Schlenz, Ph.D.¹^*, Michael U Antonucci, M.D.²^*, Rebecca Cafiero, M.D.¹^*, Nina-Serena Burkett, M.D.¹^* and Julie Kanter, MD³

¹Pediatrics, Medical University of South Carolina, Charleston, SC
²Neuroradiology, Medical University of South Carolina, Charleston, SC
³Division of Pediatric Hematology-Oncology, Department of Pediatrics, Medical University of South Carolina, Charleston, SC

2072

Aspergillus Specific PCR and Galactomannan of Bronchoalveolar Lavage Are Superior to Concomitant Same-Day Testing of Concurrent Blood Samples in Immunocompromised Hematological Patients with Suspected Invasive Aspergillosis

Tobias Boch, MD¹^*, Birgit Spiess, PhD²^*, Oliver Cornely, MD³^*, Werner J. Heinz, MD⁴^*, Joachim Hahn, MD⁵^*, Stefan W. Krause, MD⁶^*, Hartmut Bertz, MD⁷^*, Wolf-Karsten Hofmann, MD⁸, Dieter Buchheidt, MD²^* and Mark Reinwald, MD⁹^*

¹Department of Hematology and Oncology, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany
²Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany
³Klinik für InnereMedizin I, Klinikum der Universität zu Köln, Cologne, Germany
⁴Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Wuerzburg, Germany
⁵Universitätsklinikum Regensburg, Regensburg, Germany
⁶Medizinische Klinik 5, Hämatologie und Internistische Onkologie, Universitätsklinikum Erlangen, Erlangen, Germany
⁷University Medical Center Freiburg, Freiburg, Germany
⁸III. Medizinische Klinik, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany
⁹Universitätsmedizin Mannheim, Mannheim, Germany

2073

Hospitalizations and Mortality Associated with dsDNA Viral Infections Among Hematopoietic Cell Transplant Recipients

Essy Mozaffari, PharmD, MPH, MBA¹^*, Jay Lin, PhD, MBA²^* and Melissa Lingohr-Smith, PhD²^*

¹Chimerix Inc., Durham, NC
²Novosys Health, Green Brook, NJ

2074

Management Experience of Peripherally Inserted Central Catheters in Pediatric Oncology Patients: A 15 Year Population-Based Study from Maritimes, Canada

Lisa Borretta¹^*, Tamara MacDonald, PharmD²^*, Victoria E. Price, MBChB, MD², Conrad Fernandez, MD², Mark Bernstein, MD²^* and Ketan Kulkarni, MD²^*

¹Pediatric Hematology Oncology, IWK Health Centre, Halifax, Halifax, NS, Canada
²Pediatric Hematology/Oncology, IWK Health Centre, Halifax, NS, Canada

2075

Darbepoetin Hits a Double As Epoetin Hits a Home Run in Response to the 2007 FDA Black Box Warning

Virginia Noxon¹^* and Charles L. Bennett, MD, PhD²

¹Clinical Pharmacy and Outcomes Research, University of South Carolina, Columbia, SC
²South Carolina Center of Economic Excellence for Medication Safety, University of South Carolina, Columbia, SC

2076

Prevalence of Pulmonary Embolism Among Patients with Acute Exacerbations of Chronic Obstructive Pulmonary: Data from Nationwide Inpatient Sample

Ranjan Pathak, MD¹, Smith Giri, MBBS², Paras Karmacharya, MD¹^* and Anthony Donato, MD MHPE³^*

¹Reading Health System, West Reading, PA
²Department of Medicine, The University of Tennessee Health Science Center, Memphis, TN
³Reading Health System, wyomissing, PA

2077

A Cost-Utility Analysis of Deferiprone Compared to Desferrioxamine and Deferasirox for the Treatment of Chronic Myocardial Iron Overload in Thalassemia Patients

Alessia Pepe¹^*, Aishah Hanif²^*, Anthony Bentley²^*, Roderick Walker²^*, Ludovica Frizziero, MD³^*, Maria Caterina Putti, MD³^*, Anna Spasiano⁴^*, Caterina Borgna-Pignatti, MD⁵^*, Aurelio Maggio⁶, Maria Giovanna Neri¹^* and Antonella Meloni¹^*

¹CMR Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy
²Abacus International, Bicester, Oxfordshire, United Kingdom
³Clinica di Emato-Oncologia Pediatrica, Azienda Ospedaliero-Universitaria di Padova, Padova, Italy
⁴Unità Operativa Semplice Dipartimentale Malattie Rare del Globulo Rosso, Azienda Ospedaliera di Rilievo Nazionale "A. Cardarelli”, Napoli, Italy
⁵Pediatric Hematology Unit, University of Ferrara, Ferrara, Italy
⁶Ematologia II con Talassemia, Ospedale, Palermo, Italy

2078

A Successful Model for Adult Emergency Medicine Protocol Implementation for Sickle Cell Disease

Payal C. Desai, MD¹, Luca Delatore, MD²^*, Deborah Hanes, NP, MSN¹^*, Amy Rettig, MSN²^*, Miranda Gill, RN, MSN²^*, Jason Walsh, RN, MBA²^*, Emily Graham, MS³^* and Eric Adkins, MD²^*

¹Division of Hematology, The Ohio State University, Columbus, OH
²Department of Emergency Medicine, The Ohio State University, Columbus, OH
³Wexner Medical Center, The Ohio State University, Columbus, OH

2079

Under-Recognition of Hemophagocytic Lymphohistiocytosis in United States' Rural, Non-Teaching Hospitals

Omer Jamy, MD¹^*, Eric Wiedower, DO², Smith Giri, MBBS¹, Benny Johnson, DO²^*, Sara E. Nunnery¹^* and Mike G. Martin, MD³

¹Department of Medicine, The University of Tennessee Health Science Center, Memphis, TN
²Division of Hematology/Oncology, Department of Medicine, The University of Tennessee Health Science Center, Memphis, TN
³Hematology/Oncology, The West Cancer Center/The University of Tennessee Health Science Center, Memphis, TN

2080

Thrombophylaxis in Patients Undergoing Bariatric Surgery

Addie A Hill, MD¹^*, Poy P Theprungsirikul, BS¹^*, Maureen T Quigley, APRN²^*, Mary E Menduni³^*, Thadeus L Trus, MD²^*, Gina L Adriales, MD²^*, Deborah L Ornstein, MD⁴ and Monic Roengvoraphoj, MD⁴^*

¹Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH
²Department of General Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH
³Dartmouth-Hitchcock Medical Center, Lebanon, NH
⁴Department of Hematology-Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, NH

2081

An Effective Screening Algorithm and a Simple DNA Sequencing Protocol for Molecular Characterization of Rare Alpha-Globin Variants

Noppacharn Uaprasert, MD¹^*, Rung Settapiboon²^*, Supaporn Amornsiriwat¹^*, Pranee Sutcharitchan, MD³^* and Ponlapat Rojnuckarin, MD, PhD⁴

¹Medicine, Faculty of Medicine Chulalongkorn University, Bangkok, Thailand
²Department of Medicine, Faculty of Medicine Chulalongkorn University, Bangkok, Thailand
³Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand
⁴Dept. of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

2082

Cost Comparison of Hematopoietic Stem Cell Transplantation and Conventional Therapy for Patients with Thalassemia Major in China

Wanxia Tan¹^*, Chunfu Li, MD², Xuedong Wu, MD³^*, Yuelin He, MD⁴^*, Xiaoqin Feng, MD, PhD⁵^*, Jianyun Liao⁶^*, Huaying Liu⁶^*, Wenfeng Xu, MD⁷^* and Yuqiong Ren⁸^*

¹Nanfang Hospital, Southern Medical University, Guangzhou, China
²Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China
³Pediatric department, Nanfang Hospital,Southern Medical University, Guangzhou, China
⁴Pediatrics department, Nanfang Hospital,Southern Medical University, Guangzhou, China
⁵Department of Pediatrics, NanFang Hospital,Southern Medical University, Guangzhou, China
⁶Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China
⁷Pediatrics, Nanfang Hospital,Southern Medical University, Guangzhou, China
⁸Nanfang Hospital, Southern Medical University, Pediatrics, China

See more of: Health Services and Outcomes Research – Non-Malignant Conditions
See more of: Oral and Poster Abstracts

<< Previous Session | Next Session >>

^*signifies non-member of ASH

901.P1.87 901. Health Services and Outcomes Research – Non-Malignant Conditions: Poster I